Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury

Frontiers in Neurology

Volumn JUL, Issue , 2012, Pages

  Kovesdi, Erzsebet ^a   Kamnaksh, Alaa ^b,c   Wingo, Daniel ^b   Ahmed, Farid ^b,c   Grunberg, Neil E ^c,d   Long, Joseph B ^e   Kasper, Christine E ^a   Agoston, Denes V ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b School of Medicine   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d Uniformed Services University of the Health Sciences   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Anti inflammatory; Neurobehavior; Proteomics; Tbi; Treatment

Indexed keywords

EID: 84865984582     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00111     Document Type: Article

References (166)

1. Abdel Baki, S. G., Schwab, B., Haber, M., Fenton, A. A., and Bergold, P. J. (2010). Minocycline syner-gizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats. PLoS ONE 5, e12490. doi:10.1371/journal.pone.0012490
2. Aderem, A., and Ulevitch, R. J. (2000). Toll-like receptors in the induction of the innate immune response. Nature 406, 782-787.
3. Agostinho, P., Cunha, R. A., and Oliveira, C. (2010). Neuroinflam-mation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 16, 2766-2778.
4. Agoston, D.V., Gyorgy, A., Eidelman, O., and Pollard, H. B. (2009). Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades. J. Neurotrauma 26, 901-911.
5. Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
6. Alano, C. C., Kauppinen, T. M., Valls, A. V., and Swanson, R. A. (2006). Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc. Natl. Acad. Sci. U.S.A. 103, 9685-9690.
7. Amiry-Moghaddam, M., and Ottersen, O. P. (2003). The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 4, 991-1001.
8. Antonenko, Y. N., Rokitskaya, T. I., Cooper, A. J., and Krasnikov, B. F. (2010). Minocycline chelates Ca2 +, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels. J. Bioenerg. Biomembr. 42, 151-163.
9. Arvin, B., Neville, L. F., Barone, F. C., and Feuerstein, G. Z. (1996). The role of inflammation andcytokinesinbrain injury. Neurosci. Biobehav. Rev. 20, 445-452.
10. Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R., Den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., and Wittchen, H. U. (2005). Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacol-ogy. J. Psychopharmacol. (Oxford) 19, 567-596.
11. Barnes, C. A. (1979). Memory deficits associated with senescence: a neuro-physiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93, 74-104.
12. Barnett, S. (1975). The Rat - A Study in Behavior. Chicago: University of Chicago Press.
13. Belanger, H. G., Vanderploeg, R. D., Curtiss, G., and Warden, D. L. (2007). Recent neuroimaging techniques in mild traumatic brain injury. J. Neuropsychiatry Clin. Neu-rosci. 19, 5-20.
14. Berman, J. W., Guida, M. P., Warren, J., Amat, J., and Brosnan, C. F. (1996). Localization of mono-cyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156, 3017-3023.
15. Bilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W., and Ethell, I. M. (2009). Minocy-cline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J. Med. Genet. 46, 94-102.
16. Blum, D., Chtarto, A., Tenenbaum, L., Brotchi, J., and Levivier, M. (2004). Clinical potential of minocycline for neurodegenerative disorders. Neuro-biol. Dis. 17, 359-366.
17. Bolivar, V. J., Caldarone, B. J., Reilly, A. A., and Flaherty, L. (2000). Habit-uation of activity in an open field: a survey of inbred strains and F1 hybrids. Behav. Genet. 30, 285-293.
18. Bremner, J. D. (2005). Effects of traumatic stress on brain structure and function: relevance to early responses to trauma. J. Trauma Dissociation 6, 51-68.
19. Bremner, J. D. (2007). Functional neu-roimaging in post-traumatic stress disorder. Expert Rev. Neurother. 7, 393-405.
20. Brenner, L. A., Vanderploeg, R. D., and Terrio, H. (2009). Assessment and diagnosis of mild traumatic brain injury, posttraumatic stress disorder, and other poly-trauma conditions: burdenof adversity hypothesis. Rehabil. Psychol. 54, 239-246.
21. Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C., and Yong, V. W. (2002). Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125, 1297-1308.
22. Buki, A., and Povlishock, J. T. (2006). All roads lead to disconnection? - Traumatic axonal injury revisited. Acta Neurochir. (Wien) 148, 181-193; discussion 193-184.
23. Bye, N., Habgood, M. D., Callaway, J. K., Malakooti, N., Potter, A., Kossmann, T., and Morganti-Kossmann, M. C. (2007). Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neu-trophil infiltration. Exp. Neurol. 204, 220-233.
24. Cacci, E., Claasen, J. H., and Kokaia, Z. (2005). Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 80, 789-797.
25. Cao, G., Clark, R. S., Pei, W., Yin, W., Zhang, F., Sun, F. Y., Graham, S. H., and Chen, J. (2003). Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J. Cereb. Blood Flow Metab. 23, 1137-1150.
26. Carobrez, A. P., and Bertoglio, L. J. (2005). Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci. Biobehav. Rev. 29, 1193-1205.
27. Casanova, J. L., Abel, L., and Quintana-Murci, L. (2011). Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemi-ological, and clinical genetics. Annu. Rev. Immunol. 29, 447-491.
28. Cernak, I., Merkle, A. C., Koliatsos, V. E., Bilik, J. M., Luong, Q. T., Mahota, T. M., Xu, L., Slack, N., Windle, D., and Ahmed, F.A.(2011). The patho-biology of blast injuries and blast-induced neurotrauma as identified using a new experimental model of injury in mice. Neurobiol. Dis. 41, 538-551.
29. Cernak, I., and Noble-Haeusslein, L. J. (2010). Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J. Cereb. Blood Flow Metab. 30, 255-266.
30. Chen, M., Ona, V. O., Li, M., Fer-rante, R. J., Fink, K. B., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Her-sch, S. M., Hobbs, W., Vonsattel, J. P., Cha, J. H., and Friedlander, R. M. (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mousemodelof Huntingtondisease. Nat. Med. 6, 797-801.
31. Chen, Y., Hallenbeck, J. M., Ruetzler, C., Bol, D., Thomas, K., Berman, N. E., and Vogel, S. N. (2003). Overexpres-sion of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J. Cereb. Blood Flow Metab. 23, 748-755.
32. Choi, Y., Kim, H. S., Shin, K. Y., Kim, E. M., Kim, M., Park, C. H., Jeong, Y. H., Yoo, J., Lee, J. P., Chang, K. A., Kim, S., and Suh, Y. H. (2007). Minocycline attenuates neu-ronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharma-cology 32, 2393-2404.
33. Cortese, B. M., and Phan, K. L. (2005). The role of glutamate in anxiety and related disorders. CNS Spectr. 10, 820-830.
34. Czlonkowska, A., and Kurkowska-Jastrzebska, I. (2011). Inflammation and gliosis in neurological diseases - clinical implications. J. Neuroim-munol. 231, 78-85.
35. Daenen, E. W., Van Der Heyden, J. A., Kruse, C. G., Wolterink, G., and Van Ree, J. M. (2001). Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus. Brain Res. 918, 153-165.
36. Deacon, R. M., and Rawlins, J. N. (2002). Learning impairments of hippocampal-lesioned mice in a paddling pool. Behav. Neurosci. 116, 472-478.
37. Doll, H., Truebel, H., Kipfmueller, F., Schaefer, U., Neugebauer, E. A., Wirth, S., and Maegele, M. (2009). Pharyngeal selective brain cooling improves neurofunctional and neu-rocognitive outcome after fluid percussion brain injury in rats. J. Neu-rotrauma 26, 235-242.
38. Doyle, K. P., Simon, R. P., and Stenzel-Poore, M. P. (2008). Mechanisms of ischemic brain damage. Neurophar-macology 55, 310-318.
39. Du, L., Zhang, X., Han, Y. Y., Burke, N. A., Kochanek, P. M., Watkins, S. C., Graham, S. H., Car-cillo, J. A., Szabo, C., and Clark, R. S. (2003). Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. J. Biol. Chem. 278, 18426-18433.
40. Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L., Luecke, S., Phebus, L. A., Bymas-ter, F. P., and Paul, S. M. (2001). Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 98, 14669-14674.
41. Du Clos, T. W. (2000). Function of C-reactive protein. Ann. Med. 32, 274-278.
42. Dunn, A. J., Swiergiel, A. H., and Pala-marchouk, V. (2004). Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann. N. Y. Acad. Sci. 1018, 25-34.
43. Fanning, W. L., Gump, D. W., and Sof-ferman, R. A. (1977). Side effects of minocycline: a double-blind study. Antimicrob. Agents Chemother. 11, 712-717.
44. Fawcett, J. (2009). Molecular control of brain plasticity and repair. Prog. Brain Res. 175, 501-509.
45. Festoff, B. W., Ameenuddin, S., Arnold, P. M., Wong, A., Santacruz, K. S., and Citron, B. A. (2006). Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J. Neurochem. 97, 1314-1326.
46. Floyd, C. L., and Lyeth, B. G. (2007). Astroglia: important mediators of traumatic brain injury. Prog. Brain Res. 161, 61-79.
47. Fox, G. B., Fan, L., Levasseur, R. A., and Faden, A. I. (1998). Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze. J. Neuro-trauma 15, 1037-1046.
48. Gage, F. H., Dunnett, S. B., and Bjork-lund, A. (1984). Spatial learning and motor deficits in aged rats. Neuro-biol. Aging 5, 43-48.
49. Gao, Y., Fang, X., Tong, Y., Liu, Y., and Zhang, B. (2009). TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed. Pharmacother. 63, 442-450.
50. Gerber, H. P., Mcmurtrey, A., Kowal-ski, J., Yan, M., Keyt, B. A., Dixit, V., and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinos-itol 3'-kinase/Akt signal transduc-tion pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30343.
51. Glabinski, A. R., Balasingam, V., Tani, M., Kunkel, S. L., Strieter, R. M., Yong, V. W., and Ranso-hoff, R. M. (1996). Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156, 4363-4368.
52. Gonzalez, L. E., and File, S. E. (1997). A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J. Neurosci. 17, 1505-1511.
53. Gump, D. W., Ashikaga, T., Fink, T. J., and Radin, A. M. (1977). Side effects of minocycline: different dosage regimens. Antimicrob. Agents Chemother. 12, 642-646.
54. Gyorgy, A., Ling, G., Wingo, D., Walker, J., Tong, L., Parks, S., Januszkiewicz, A., Baumann, R., and Agoston, D. V. (2011). Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J. Neuro-trauma 28, 1121-1126.
55. Gyorgy, A. B., Walker, J., Wingo, D., Eidelman, O., Pollard, H. B., Mol-nar, A., and Agoston, D. V. (2010). Reverse phase protein microar-ray technology in traumatic brain injury. J. Neurosci. Methods 192, 96-101.
56. Handley, S. L., and Mithani, S. (1984). Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of "fear" -motivated behaviour. Naunyn Schmiedebergs Arch. Pharmacol. 327, 1-5.
57. Harrison, F. E., Hosseini, A. H., and Mcdonald, M. P. (2009). Endogenous anxiety and stress responses in water maze and Barnes maze spatial memorytasks. Behav. Brain Res.198, 247-251.
58. Henke, P.G.(1990). Hippocampal pathway to the amygdala and stress ulcer development. Brain Res. Bull. 25, 691-695.
59. Heo, K., Cho, Y. J., Cho, K. J., Kim, H. W., Kim, H. J., Shin, H. Y., Lee, B. I., and Kim, G. W. (2006). Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hip-pocampal damage after treatment with kainic acid in mice. Neurosci. Lett. 398, 195-200.
60. Hewlett, K. A., and Corbett, D. (2006). Delayed minocycline treatment reduces long-term functional deficits and histological injury in a rodent model of focal ischemia. Neuroscience 141, 27-33.
61. Hoffer, M. E., Balaban, C., Gottshall, K., Balough, B. J., Maddox, M. R., and Penta, J. R. (2010). Blast exposure: vestibular consequences and associated characteristics. Otol. Neurotol. 31, 232-236.
62. Hoge, C. W., Mcgurk, D., Thomas, J. L., Cox, A. L., Engel, C. C., and Castro, C. A. (2008). Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N. Engl. J. Med. 358, 453-463.
63. Holmes, A., Wrenn, C. C., Harris, A. P., Thayer, K. E., and Crawley, J. N. (2002). Behavioral profiles of inbred strainson novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav. 1, 55-69.
64. Hua, F., Ma, J., Ha, T., Kelley, J. L., Kao, R. L., Schweitzer, J. B., Kalbfleisch, J. H., Williams, D. L., and Li, C. (2009). Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res. 1262, 100-108.
65. Hua, F., Ma, J., Ha, T., Xia, Y., Kelley, J., Williams, D. L., Kao, R. L., Browder, I. W., Schweitzer, J. B., Kalbfleisch, J. H., and Li, C. (2007). Activation of Toll-like receptor 4 signaling contributestohippocampal neu-ronal death following global cerebral ischemia/reperfusion. J. Neu-roimmunol. 190, 101-111.
66. Hyder, A. A., Wunderlich, C. A., Puvanachandra, P., Gururaj, G., and Kobusingye, O. C. (2007). The impact of traumatic brain injuries: a global perspective. NeuroRehabili-tation 22, 341-353.
67. Ingram, D. K., London, E. D., and Goodrick, C. L. (1981). Age and neurochemical correlates of radial maze performance inrats.Neurobiol. Aging 2, 41-47.
68. Kamnaksh, A., Kovesdi, E., Kwon, S. K., Wingo, D., Ahmed, F., Grunberg, N. E., Long, J., and Agoston, D. V. (2011). Factors affecting blast traumatic brain injury. J. Neurotrauma 28, 2145-2153.
69. Kersel, D. A., Marsh, N. V., Havill, J. H., and Sleigh, J. W. (2001). Psychoso-cial functioning during the year following severe traumatic brain injury. Brain Inj. 15, 683-696.
70. Kilic, E., Kilic, U., Wang, Y., Bassetti, C. L., Marti, H.H.,andHermann, D.M. (2006). The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 20, 1185-1187.
71. Kimelberg, H. K. (1995). Current concepts of brain edema. Review of laboratory investigations. J. Neurosurg. 83, 1051-1059.
72. Kochanek, P. M., Berger, R. P., Bayir, H., Wagner, A. K., Jenkins, L. W., and Clark, R. S. (2008). Biomark-ers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care 14, 135-141.
73. Korte, S. M., and De Boer, S. F. (2003). A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur. J. Pharmacol. 463, 163-175.
74. Kovesdi, E., Gyorgy, A. B., Kwon, S. K., Wingo, D. L., Kamnaksh, A., Long, J. B., Kasper, C. E., and Agoston, D. V. (2011). The effect of enriched environment on the outcome of traumatic brain injury; abehavioral, proteomics, and histological study. Front. Neurosci. 5:42. doi:10.3389/fnins.2011.00042
75. Kriz, J., Nguyen, M. D., and Julien, J. P. (2002). Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neuro-biol. Dis. 10, 268-278.
76. Kwon, S. K., Kovesdi, E., Gyorgy, A. B., Wingo, D., Kamnaksh, A., Walker, J., Long, J. B., and Agoston, D. V. (2011). Stress and traumatic brain injury: a behavioral, proteomics, and histological study. Front. Neurol. 2:12. doi:10.3389/fneur.2011.00012
77. Lamberty, Y., and Gower, A. J. (1993). Spatial processing and emotionality in aged NMRI mice: a multivariate analysis. Physiol. Behav. 54, 339-343.
78. Lee, C., and Agoston, D. V. (2009). Inhibition of VEGF receptor 2 increased cell death of dentate hilar neurons after traumatic brain injury. Exp. Neurol. 220, 400-403.
79. Lee, C., and Agoston, D. V. (2010). Vascular endothelial growth factor is involved in mediating increased de novo hippocampal neurogenesis in response to traumatic brain injury. J. Neurotrauma 27, 541-553.
80. Lee, J. H., Tigchelaar, S., Liu, J., Stammers, A. M., Streijger, F., Tetzlaff, W., and Kwon, B. K. (2010). Lack of neuroprotective effects of simvas-tatin and minocycline in a model of cervical spinal cord injury. Exp. Neurol. 225, 219-230.
81. Lee, S. M., Yune, T. Y., Kim, S. J., Park Do, W., Lee, Y. K., Kim, Y. C., Oh, Y. J., Markelonis, G. J., and Oh, T. H. (2003). Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma 20, 1017-1027.
82. Li, J., and McCullough, L. D. (2009). Sex differences in minocycline-induced neuroprotection after experimental stroke. J. Cereb. Blood Flow Metab. 29, 670-674.
83. Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E. H., Kalbacher, H., and Wolburg, H. (2000). Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 100, 323-331.
84. Ling, G., Bandak, F., Armonda, R., Grant, G., and Ecklund, J. (2009). Explosive blast neurotrauma. J. Neu-rotrauma 26, 815-825.
85. Ling, G. S., and Ecklund, J. M. (2011). Traumatic brain injury in modern war. Curr. Opin. Anaesthesiol. 24, 124-130.
86. Lobo, S. M., Lobo, F. R., Bota, D. P., Lopes-Ferreira, F., Soliman, H. M., Melot, C., and Vincent, J. L. (2003). C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123, 2043-2049.
87. Long, J. B., Bentley, T. L., Wessner, K. A., Cerone, C., Sweeney, S., and Bau-man, R.A. (2009). Blast overpressure in rats: recreating a battlefield injury in the laboratory. J. Neurotrauma 26, 827-840.
88. Losy, J., and Zaremba, J. (2001). Mono-cyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 32, 2695-2696.
89. Macdonald, H., Kelly, R. G., Allen, E. S., Noble, J. F., and Kanegis, L. A. (1973). Pharmacokinetic studies on minocycline in man. Clin. Pharmacol. Ther. 14, 852-861.
90. Maegele, M., Lippert-Gruener, M., Ester-Bode, T., Sauerland, S., Schafer, U., Molcany, M., Lefering, R., Bouillon, B., Neiss, W. F., Angelov, D. N., Klug, N., Mcintosh, T. K., and Neugebauer, E. A. (2005). Reversal of neuromotor and cognitive dysfunction in an enriched environment combined with multimodal early onset stimulation after traumatic brain injury in rats. J. Neuro-trauma 22, 772-782.
91. Marchand, F., Tsantoulas, C., Singh, D., Grist, J., Clark, A. K., Bradbury, E. J., and Mcmahon, S. B. (2009). Effects of Etanercept and Minocycline in a rat model of spinal cord injury. Eur. J. Pain 13, 673-681.
92. Marsh, B. J., Williams-Karnesky, R. L., and Stenzel-Poore, M. P. (2009). Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 1007-1020.
93. Mastroianni, C. M., Lancella, L., Men-goni, F., Lichtner, M., Santopadre, P., D'Agostino, C., Ticca, F., and Vullo, V. (1998). Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis. Clin. Exp. Immunol. 114, 210-214.
94. Mishra, B. B., Mishra, P. K., and Teale, J. M. (2006). Expression and distribution of Toll-like receptors in the brain during murine neurocysticer-cosis. J. Neuroimmunol. 181, 46-56.
95. Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., and Hagen-strom, H. (1999). Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminaryclinical results.Clin. Chem. 45, 138-141.
96. Miyakawa, T., Yared, E., Pak, J. H., Huang, F.L., Huang, K.P.,and Craw-ley, J. N. (2001). Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components. Hippocampus 11, 763-775.
97. Morganti-Kossmann, M. C., Rancan, M., Stahel, P. F., and Kossmann, T. (2002). Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 8, 101-105.
98. Morita, K., Sasaki, H., Furuse, M., and Tsukita, S. (1999). Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147, 185-194.
99. Moser, M. B., and Moser, E. I. (1998). Functional differentiation in the hippocampus. Hippocampus 8, 608-619.
100. Neal, C. J., Lee, E. Y., Gyorgy, A., Eck-lund, J. M., Agoston, D. V., and Ling, G. S. (2007). Effect of penetrating brain injury on aquaporin-4 expression using a rat model. J. Neurotrauma 24, 1609-1617.
101. Neigh, G. N., Karelina, K., Glasper, E. R., Bowers, S. L., Zhang, N., Popovich, P. G., and Devries, A. C. (2009). Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke 40, 3601-3607.
102. Nelson, L. A., Yoash-Gantz, R. E., Pick-ett, T. C., and Campbell, T. A. (2009). Relationship between processing speed andexecutive functioning performance among OEF/OIF veterans: implications for postdeploy-ment rehabilitation. J. Head Trauma Rehabil. 24, 32-40.
103. Ng, S. Y., Semple, B. D., Morganti-Kossmann, M. C., and Bye, N. (2012). Attenuation of microglial activation with minocycline is not associated with changes in neuro-genesis after focal traumatic brain injury in adult mice. J. Neurotrauma 29, 1410-1425.
104. Ogunshola, O. O., Antic, A., Donoghue, M. J., Fan, S. Y., Kim, H., Stewart, W. B., Madri, J. A., and Ment, L. R. (2002). Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277, 11410-11415.
105. Okamura, J. M., Miyagi, J. M., Ter-ada, K., and Hokama, Y. (1990). Potential clinical applications of C-reactive protein. J. Clin. Lab. Anal. 4, 231-235.
106. Okie, S. (2005). Traumatic brain injury in the war zone. N. Engl. J. Med. 352, 2043-2047.
107. O'Neill, L. A. (2006). How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9.
108. Overstreet, D. H., Commissaris, R. C., De La Garza, R. II, File, S. E., Knapp, D. J., and Seiden, L. S. (2003). Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6, 101-110.
109. Papadopoulos, M. C., Krishna, S., and Verkman, A. S. (2002). Aquaporin water channels and brain edema.Mt. Sinai J. Med. 69, 242-248.
110. Patel, R. N., Attur, M. G., Dave, M. N., Patel, I. V., Stuchin, S. A., Abramson, S. B., and Amin, A.R. (1999).Anovel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production. J. Immunol. 163, 3459-3467.
111. Paylor, R., Zhao, Y., Libbey, M., West-phal, H., and Crawley, J. N. (2001). Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol. Behav. 73, 781-792.
112. Pellow, S., Chopin, P., File, S. E., and Briley, M. (1985). Validation of open:closed arm entries in an ele-vatedplus-mazeasameasureof anxiety in the rat. J. Neurosci. Methods 14, 149-167.
113. Pitkänen, A., Schwartzkroin, P. A., and Moshé, S. L. (2006). Models of Seizures and Epilepsy. San Diego: Academic Press.
114. Pompl, P. N., Mullan, M. J., Bjugstad, K., and Arendash, G. W. (1999). Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. J. Neurosci. Methods 87, 87-95.
115. Popovic, N., Schubart, A., Goetz, B. D., Zhang, S. C., Linington, C., and Duncan, I. D. (2002). Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann. Neurol. 51, 215-223.
116. Povlishock, J. T., and Christman, C. W. (1995). The pathobiology of trau-matically induced axonal injury in animals and humans: a review of current thoughts. J. Neurotrauma 12, 555-564.
117. Povlishock, J. T., and Pettus, E. H. (1996). Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. Acta Neurochir. Suppl. 66, 81-86.
118. Prat, A., and Antel, J. (2005). Pathogen-esis of multiple sclerosis. Curr. Opin. Neurol. 18, 225-230.
119. Quinn, R. (2005). Comparing rat's to human's age: how old is my rat in people years? Nutrition 21, 775-777.
120. Raber, J., Rola, R., Lefevour, A., Morhardt, D., Curley, J., Mizumatsu, S., Vandenberg, S. R., and Fike, J. R. (2004). Radiation-induced cognitive impairments are associated with changes in indicators of hippocam-pal neurogenesis. Radiat. Res. 162, 39-47.
121. Rancan, M., Otto, V. I., Hans, V. H., Gerlach, I., Jork, R., Trentz, O., Kossmann, T., and Morganti-Kossmann, M. C. (2001). Upregula-tion of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats. J. Neurosci. Res. 63, 438-446.
122. Rapoport, M. J., Mccullagh, S., Shammi, P., and Feinstein, A. (2005). Cognitive impairment associated with major depression following mild and moderate traumatic brain injury. J. Neuropsychiatry Clin. Neu-rosci. 17, 61-65.
123. Rickels, K., Case, W. G., Schweizer, E., Garcia-Espana, F., and Fridman, R. (1991). Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am. J. Psychiatry 148, 757-761.
124. Robel, S., Berninger, B., and Gotz, M. (2011). The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 12, 88-104.
125. Rodgers, R. J., Lee, C., and Shepherd, J. K. (1992). Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl.) 106, 102-110.
126. Rosenstein, J. M., Mani, N., Khaibul-lina, A., and Krum, J. M. (2003). Neurotrophic effects of vascular endothelial growth factor on organ-otypic cortical explants and primary cortical neurons. J. Neurosci. 23, 11036-11044.
127. Ryan, L. M., and Warden, D. L. (2003). Post concussion syndrome. Int. Rev. Psychiatry 15, 310-316.
128. Saivin, S., and Houin, G. (1988). Clinical pharmacokinetics of doxycy-cline and minocycline. Clin. Phar-macokinet. 15, 355-366.
129. Salzberg, M., Kumar, G., Supit, L., Jones, N. C., Morris, M. J., Rees, S., and O'Brien, T. J. (2007). Early postnatal stress confers enduring vulnerability to limbic epileptogenesis. Epilepsia 48, 2079-2085.
130. Sanchez Mejia, R. O., Ona, V. O., Li, M., and Friedlander, R. M. (2001). Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neuro-surgery 48, 1393-1399; discussion 1399-1401.
131. Silva, R. C., and Brandao, M. L. (2000). Acute and chronic effectsof gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol. Biochem. Behav. 65, 209-216.
132. Silveira, M. C., Sandner, G., and Gra-eff, F. G. (1993). Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze. Behav. Brain Res. 56, 115-118.
133. Silver, J. M., Mcallister, T. W., and Arcin-iegas, D. B. (2009). Depression and cognitive complaints following mild traumatic brain injury. Am. J. Psychiatry 166, 653-661.
134. Sindern, E., Niederkinkhaus, Y., Hen-schel, M., Ossege, L. M., Patzold, T., and Malin, J. P. (2001). Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis. Acta Neurol. Scand. 104, 88-91.
135. Siopi, E., Cho, A. H., Homsi, S., Croci, N., Plotkine, M., Marchand-Leroux, C., and Jafarian-Tehrani, M. (2011). Minocycline restores sAPPalpha levels and reduces the late histopatho-logical consequences of traumatic brain injury in mice. J. Neurotrauma 28, 2135-2143.
136. Skold, M. K., Risling, M., and Holmin, S. (2006). Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. Eur. J. Neurosci. 23, 21-34.
137. Sondell, M., Sundler, F., and Kanje, M. (2000). Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 12, 4243-4254.
138. Sorensen, T. L., Ransohoff, R. M., Stri-eter, R. M., and Sellebjerg, F. (2004). Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur. J. Neurol. 11, 445-449.
139. Sprott, R. L., and Eleftheriou, B. E. (1974). Open-field behavior in aging inbred mice. Gerontologia 20, 155-162.
140. Stamatovic, S. M., Dimitrijevic, O. B., Keep, R. F., and Andjelkovic, A. V. (2006). Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J. Biol. Chem. 281, 8379-8388.
141. Stamatovic, S. M., Keep, R. F., Kunkel, S. L., and Andjelkovic, A. V. (2003). Potential role of MCP-1 in endothe-lial cell tight junction "opening": signaling via Rho and Rho kinase. J. Cell Sci. 116, 4615-4628.
142. Stirling, D. P., Khodarahmi, K., Liu, J., Mcphail, L. T., Mcbride, C. B., Steeves, J. D., Ramer, M. S., and Tetzlaff, W. (2004). Minocycline treatment reduces delayed oligo-dendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24, 2182-2190.
143. Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., and Tetzlaff, W. (2005). Minocycline as a neuroprotective agent. Neuroscientist 11, 308-322.
144. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Laro-chette, N., Goodlett, D. R., Aeber-sold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. (1999). Molecular characterization of mito-chondrial apoptosis-inducing factor. Nature 397, 441-446.
145. Takeda, K., and Akira, S. (2005). Tolllike receptors in innate immunity. Int. Immunol. 17, 1-14.
146. Tanielian, T., and Jaycox, L. H. (2008). Invisible Wounds of War: Psychological and Cognitive Injuries, their Consequences, and Services to Assist Recovery. Santa Monica:RAND Corporation.
147. Tekstra, J., Beekhuizen, H., Van De Gevel, J. S., Van Benten, I. J., Tuk, C. W., and Beelen, R. H. (1999). Infection of human endothelial cells with Staphylococcus aureus induces the production of mono-cyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis. Clin. Exp. Immunol. 117, 489-495.
148. Teng, Y.D., Choi, H., Onario, R. C., Zhu, S., Desilets, F. C., Lan, S., Woodard, E. J., Snyder, E. Y., Eichler, M. E., and Friedlander, R. M. (2004). Minocy-cline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 101, 3071-3076.
149. Tenovuo, O. (2006). Pharmacological enhancement of cognitive and behavioral deficits after traumatic brain injury. Curr. Opin. Neurol. 19, 528-533.
150. Terrio, H., Brenner, L. A., Ivins, B. J., Cho, J. M., Helmick, K., Schwab, K., Scally, K., Bretthauer, R., and Warden, D. (2009). Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team. J. Head Trauma Rehabil. 24, 14-23.
151. Thurman, D. J., Alverson, C., Dunn, K. A., Guerrero, J., and Sniezek, J. E. (1999). Traumatic brain injury inthe United States: a public health perspective. J. Head Trauma Rehabil. 14, 602-615.
152. Tikka, T. M., and Koistinaho, J. E. (2001). Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166, 7527-7533.
153. Walf, A. A., and Frye, C. A. (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322-328.
154. Wang, X., Zhu, S., Drozda, M., Zhang, W., Stavrovskaya, I. G., Cattaneo, E., Ferrante, R. J., Kristal, B. S., and Friedlander, R. M. (2003). Minocy-cline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Hunt-ington's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 10483-10487.
155. Warden, D. (2006). Military TBI during the Iraq and Afghanistan wars. J. Head Trauma Rehabil. 21, 398-402.
156. Wells, J. E., Hurlbert, R. J., Fehlings, M. G., and Yong, V. W. (2003). Neu-roprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126, 1628-1637.
157. Wixey, J. A., Reinebrant, H. E., Spencer, S. J., and Buller, K. M. (2011). Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia-induced damage to the serotonergic system in the immature rat brain. Neuroscience 182, 184-192.
158. Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H., and Przedborski, S. (2002). Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771.
159. Wu, L. W., Mayo, L. D., Dunbar, J. D., Kessler, K. M., Baerwald, M. R., Jaffe, E. A., Wang, D., Warren, R. S., and Donner, D. B. (2000). Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mito-gens in the induction of endothelial cell proliferation. J. Biol. Chem. 275, 5096-5103.
160. Xu, L., Fagan, S. C., Waller, J. L., Edwards, D., Borlongan, C. V., Zheng, J., Hill, W. D., Feuerstein, G., and Hess, D. C. (2004). Low dose intravenous minocycline is neu-roprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol. 4,7. doi:10.1186/1471-2377-4-7
161. Yrjanheikki, J., Keinanen, R., Pel-likka, M., Hokfelt, T., and Koisti-naho, J. (1998). Tetracyclines inhibit microglial activation and are neuro-protective in global brain ischemia. Proc. Natl. Acad. Sci. U.S.A. 95, 15769-15774.
162. Yrjanheikki, J., Tikka, T., Keina-nen, R., Goldsteins, G., Chan, P. H., and Koistinaho, J. (1999). A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 96, 13496-13500.
163. Yune, T. Y., Lee, J. Y., Jung, G. Y., Kim, S. J., Jiang, M. H., Kim, Y. C., Oh, Y. J., Markelonis, G. J., and Oh, T. H. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 27, 7751-7761.
164. Zemke, D., and Majid, A. (2004). The potential of minocycline for neu-roprotection in human neurologic disease. Clin. Neuropharmacol. 27, 293-298.
165. Zhang, X., Chen, J., Graham, S. H., Du, L., Kochanek, P. M., Draviam, R., Guo, F., Nathaniel, P. D., Szabo, C., Watkins, S. C., and Clark, R. S. (2002). Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82, 181-191.
166. Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., Gullans, S., Ferrante, R. J., Przedborski, S., Kristal, B. S., and Friedlander, R. M. (2002). Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74-78.